Raymond James Financial Inc. Decreases Stock Position in HealthEquity, Inc. $HQY

Key Points

• Raymond James Financial Inc. reduced its stake in HealthEquity, Inc. by 9.0%, selling 42,949 shares and owning 433,628 shares worth approximately $38.32 million as of the latest reporting period.
• HealthEquity recently received positive analyst rating upgrades, with several firms raising their target prices, including Deutsche Bank and Bank of America, who set target prices at $115.00 and $125.00 respectively.
• Insiders at HealthEquity have recently sold significant amounts of stock, with the Director Jon Kessler selling 134,183 shares and Executive Vice President Elimelech Rosner selling 58,000 shares, indicating a potential shift in internal sentiment.

Raymond James Financial Inc. lessened its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 9.0% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 433,628 shares of the company's stock after selling 42,949 shares during the quarter. Raymond James Financial Inc. owned about 0.50% of HealthEquity worth $38,320,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of HQY. Hancock Whitney Corp raised its position in shares of HealthEquity by 1.0% in the 4th quarter. Hancock Whitney Corp now owns 13,326 shares of the company's stock valued at $1,279,000 after purchasing an additional 133 shares in the last quarter. Xponance Inc. raised its position in shares of HealthEquity by 1.1% in the 1st quarter. Xponance Inc. now owns 12,412 shares of the company's stock valued at $1,097,000 after purchasing an additional 136 shares in the last quarter. Fifth Third Bancorp raised its position in shares of HealthEquity by 17.5% in the 1st quarter. Fifth Third Bancorp now owns 955 shares of the company's stock valued at $84,000 after purchasing an additional 142 shares in the last quarter. Greenleaf Trust raised its position in shares of HealthEquity by 7.8% in the 1st quarter. Greenleaf Trust now owns 2,407 shares of the company's stock valued at $213,000 after purchasing an additional 175 shares in the last quarter. Finally, State of Alaska Department of Revenue raised its position in shares of HealthEquity by 1.8% in the 1st quarter. State of Alaska Department of Revenue now owns 10,136 shares of the company's stock valued at $895,000 after purchasing an additional 180 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company's stock.

Insider Activity at HealthEquity

In related news, Director Jon Kessler sold 134,183 shares of the business's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $112.08, for a total transaction of $15,039,230.64. Following the completion of the transaction, the director owned 253,510 shares in the company, valued at $28,413,400.80. The trade was a 34.61% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Elimelech Rosner sold 58,000 shares of the business's stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $112.56, for a total value of $6,528,480.00. Following the transaction, the executive vice president owned 75,689 shares of the company's stock, valued at $8,519,553.84. This represents a 43.38% decrease in their position. The disclosure for this sale can be found here. Insiders sold 291,744 shares of company stock worth $32,705,007 in the last 90 days. 1.50% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Wall Street Zen raised HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. Deutsche Bank Aktiengesellschaft upped their target price on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a research report on Thursday, June 5th. Bank of America upped their target price on HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a research report on Wednesday, June 4th. Barrington Research upped their target price on HealthEquity from $112.00 to $125.00 and gave the company an "outperform" rating in a research report on Thursday, June 5th. Finally, JMP Securities upped their target price on HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a research report on Wednesday, June 4th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Buy" and an average target price of $118.55.

HealthEquity Price Performance

HQY opened at $89.82 on Friday. HealthEquity, Inc. has a fifty-two week low of $73.84 and a fifty-two week high of $116.65. The firm has a market cap of $7.77 billion, a price-to-earnings ratio of 65.56, a price-to-earnings-growth ratio of 1.41 and a beta of 0.54. The company has a quick ratio of 4.06, a current ratio of 4.06 and a debt-to-equity ratio of 0.50. The company's 50-day moving average price is $96.78 and its 200 day moving average price is $96.64.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%.The business had revenue of $330.80 million during the quarter, compared to analyst estimates of $322.25 million. During the same quarter in the previous year, the firm posted $0.80 EPS. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. As a group, sell-side analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.